Memphasys Limited
Memphasys Limited (MEM.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Memphasys Limited (MEM.AX), covering cash flow, earnings, and balance sheets.
Memphasys Limited (MEM.AX) Income Statement & Financial Overview
Analyze Memphasys Limited’s MEM.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $325344.00 | $24000.00 | $36000.00 | $11100.00 |
| Cost of Revenue | $50593.00 | $615582.00 | $1.07M | $719837.00 |
| Gross Profit | $274751.00 | -$591582.00 | -$1.03M | -$708737.00 |
| Gross Profit Ratio | $0.84 | -$24.65 | -$28.71 | -$63.85 |
| R&D Expenses | $784057.00 | $1.44M | $700379.00 | $954100.00 |
| SG&A Expenses | $625021.00 | $717130.00 | $757825.00 | $719054.00 |
| Operating Expenses | $1.41M | $2.21M | $1.46M | $1.67M |
| Total Costs & Expenses | $1.46M | $2.77M | $2.53M | $2.39M |
| Interest Income | $0.00 | $0.00 | $6105.00 | $7778.00 |
| Interest Expense | $0.00 | $295639.00 | $121494.00 | $249060.00 |
| Depreciation & Amortization | $69665.00 | $391559.00 | $325604.00 | $553960.00 |
| EBITDA | -$1.60M | -$1.45M | -$1.86M | -$1.42M |
| EBITDA Ratio | -$4.93 | -$60.51 | -$51.54 | -$164.68 |
| Operating Income | -$1.13M | -$2.75M | -$2.49M | -$2.38M |
| Operating Income Ratio | -$3.49 | -$114.46 | -$69.22 | -$214.58 |
| Other Income/Expenses (Net) | -$1.83M | $607434.00 | $189275.00 | -$1.07M |
| Income Before Tax | -$2.97M | -$2.14M | -$2.30M | -$2.22M |
| Income Before Tax Ratio | -$9.12 | -$89.15 | -$63.96 | -$199.92 |
| Income Tax Expense | $0.00 | $0.00 | -$4.00 | $0.00 |
| Net Income | -$2.97M | -$2.14M | -$2.30M | -$2.22M |
| Net Income Ratio | -$9.12 | -$89.15 | -$63.96 | -$199.92 |
| EPS | -$1.90 | -$0.001 | -$0.002 | -$0.002 |
| Diluted EPS | -$1.90 | -$0.001 | -$0.002 | -$0.002 |
| Weighted Avg Shares Outstanding | $1.56M | $2.31B | $1.13B | $1.002B |
| Weighted Avg Shares Outstanding (Diluted) | $1.56M | $2.31B | $1.13B | $1.002B |
The company's financials show resilient growth, with revenue advancing from $11100.00 in Q4 2023 to $325344.00 in Q2 2025. Gross profit remained healthy with margins at 84% in Q2 2025 compared to -6385% in Q4 2023. Operating income hit -$1.13M last quarter, sustaining a consistent -349% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$1.60M. Net income dropped to -$2.97M, while earnings per share reached -$1.90. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan